General communications


Changeover to electronic submission of notifications of major changes from autumn 2020

Planned changes affecting establishment licence holders


A study confirms Swissmedic’s international Competitiveness

In an international comparison of the processing time for scientific assessments, Swissmedic is on a par with the fastest authorities


Swissmedic extends the use of remdesivir

With immediate effect, remdesivir can be used more widely in Switzerland for the treatment of COVID-19 patients


Regulatory authorities step up cooperation in connection with COVID-19

Further details on observational research


Optimisation of labelling phase for human medicinal products

Avoiding text review rounds


List of medicinal products in dispensing category D dispensed by naturopaths with a federal diploma (NP FD)

Human medicinal products in dispensing category D that may be dispensed by naturopaths


Virtual meetings instead of ICH meetings in Vancouver during the COVID-19 pandemic

ICH Working Groups continue their activities online


Submission of DMF updates

Type II variations now possible


Annexes of two Swissmedic ordinances amended

The Institute Council has put into force the updating of Annexes 3a and 7 of the Medicinal Products Authorisation Ordinance and Annexes 2 and 3 of the Ordinance concerning simplified Marketing Authorisations on 1 July 2020.

Last modification 29.03.2020

Top of page